JPMorgan Chase & Co. Boosts Globe Life (NYSE:GL) Price Target to $181.00

Globe Life (NYSE:GL) had its price target boosted by equities researchers at JPMorgan Chase & Co. from $180.00 to $181.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 23.45% from the stock’s previous close.

Several other equities research analysts also recently weighed in on GL. Morgan Stanley reissued an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Weiss Ratings lowered Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. Keefe, Bruyette & Woods upped their price objective on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Wells Fargo & Company dropped their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Finally, Piper Sandler reiterated an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research report on Friday, November 21st. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $171.00.

Globe Life Stock Down 0.2%

GL stock opened at $146.62 on Thursday. The firm has a 50-day moving average price of $139.38 and a 200-day moving average price of $137.97. Globe Life has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $11.67 billion, a P/E ratio of 10.41 and a beta of 0.47.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.Globe Life’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, equities research analysts anticipate that Globe Life will post 13.87 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Frank M. Svoboda sold 9,379 shares of the business’s stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,036,943.24. The trade was a 20.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Globe Life

A number of hedge funds have recently bought and sold shares of GL. Transcend Capital Advisors LLC lifted its position in shares of Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares in the last quarter. Natural Investments LLC increased its position in shares of Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the last quarter. Intech Investment Management LLC lifted its holdings in Globe Life by 0.8% during the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after acquiring an additional 95 shares during the period. CX Institutional boosted its position in Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company’s stock worth $258,000 after purchasing an additional 96 shares during the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC grew its stake in Globe Life by 2.2% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.